Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells

Journal of Clinical Investigation

Volumn 98, Issue 9, 1996, Pages 2129-2138

  Zhou, Yi Fu ^a   Guetta, Esther ^a   Yu, Zu Xi ^a   Finkel, Toren ^a   Epstein, Stephen E ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

atherosclerosis; immediate early genes; immunohistochemistry; reverse transcriptase polymerase chain reaction; transfection

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; FUCOIDIN; GENE PRODUCT; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; RECEPTOR;

ANIMAL CELL; ARTERIOSCLEROSIS; ARTICLE; ATHEROGENESIS; FOAM CELL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; LIPID STORAGE; LIPID TRANSPORT; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECEPTOR GENE; REPORTER GENE; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VIRUS INFECTION;

EID: 0000353830     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119019     Document Type: Article

References (56)

1. Bruggeman, C.A., and M.C.E. Van Dam-Mieras. 1991. The possible role of cytomegalovirus in atherogenesis. Prog. Med. Virol. 38:1-26.
2. Melnick, J.L., E. Adam, and M.E. Debakey. 1993. Cytomegalovirus and atherosclerosis. Eur. Heart J. 14(Suppl. K):30-38.
3. Hendrix, M.G.R., M. Daemen, and C.A. Bruggeman. 1991. Cytomegalovirus nucleic acid distribution within the human vascular tree. Am. J. Pathol. 138:563-567.
4. Melnick, J.L., C. Hu, J. Burek, E. Adam, and M.E. Debakey. 1994. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J. Med. Virol. 42:170-174.
5. Loebe, M., S. Schuler, O. Zais, H. Warnecke, E. Fleck, and R. Hetzer. 1990. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J. Heart Transplant. 9:707-711.
6. Grattan, M.T., C.E. Moreno-Cabral, V.A. Starnes, P.E. Oyer, E.B. Stinson, and N.E. Shumway. 1989. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA (J. Am. Med. Assoc.) 261: 3561-3566.
7. Melnick, J.L., E. Adam, and M.E. DeBakey. 1990. Possible role of cytomegaiovirus in atherosclerosis. JAMA (J. Am. Med. Assoc.). 263:2204-2207.
8. Fabricant, C.G., J. Fabricant, M.M. Litrenta, and C.R. Minick. 1978. Virus-induced atherosclerosis. J. Exp. Med. 148:335-340.
9. Minick, C.R., C.G. Fabricant, J. Fabricant, and M.M. Litrenta. 1979. Atheroarteriosclerosis induced by infection with a herpes virus. Am. J. Pathol. 96:673-706.
10. Hajjar, D.P., C.G. Fabricant, C.R. Minick, and J. Fabricant. 1986. Virus-induced atherosclerosis: herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am. J. Pathol. 122:62-70.
11. Hajjar, D.P. 1986. Herpesvirus infection prevents activation of cytoplasmic cholesteryl esterase in arterial smooth muscle cells. J. Biol. Chem. 261: 7611-7614.
12. Steinberg, D. 1991. Lipoprotein modification and atherogenesis. Atheroscler. Rev. 23:115-121.
13. Brown, M.S., and J.L. Goldstein. 1984. How LDL receptors influence cholesterol and atherosclerosis. Sci. Am. 251:58-66.
14. Gil, G., T.F. Osborne, J.L. Goldstein, and M.S. Brown. 1988. Purification of a protein doublet that binds to six TGG-containing sequences in the promoter for hamster 3-hydroxy-3-methylglutaryl-COA-reductase. J. Biol. Chem. 263:19009-19019.
15. Leake, D.S., and S.M. Rankin. 1990. The oxidative modification of low density lipoproteins by macrophages. Biochem. J. 270:741-748.
16. Goldstein, J.L., Y.K. Ho, S.K. Basu, and M.S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76:333-337.
17. Yla-herttuala, S., M.E. Rosenfeld, S. Parthasarathy, E. Sigal, T. Sarkioja, J.L. Witztum, and D. Steinberg. 1991. Gene expression in macrophage-rich human atherosclerotic lesions. 15-Lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J. Clin. Invest. 87:1146-1152.
18. Freeman, M., Y. Ekkel, L. Rohrer, M. Penman, N.J. Freedman, G.M. Chisolm, and M. Krieger. 1991. Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 88:4931-4935.
19. Wolle, S., D.P. Via, L. Chan, J.A. Cornicelli, and C.L. Bisgaier. 1995. Hepatic overexpression of bovine scavenger receptor type I in transgenic mice prevents diet-induced hyperbetalipoproteinemia. J. Clin. Invest. 96:260-272.
20. Brown, M.S., and J.L. Goldstein. 1990. Scavenging for receptors. Nature (Lond.). 343:508-509.
21. Campbell, J.H., and G.R. Campbell. 1987. Methods of growing vascular smooth muscle in culture. In Vascular Smooth Muscle in Culture. J.H. Campbell, and G.R. Campbell, editors. CRC Press Inc., Boca Raton, FL. 15-21.
22. Watanabe, Y., T. Inaba, H. Shimano, T. Gotoda, K. Yamanoto, H. Mokuno, H. Sato, Y. Yazaki, and N. Yamada. 1994. Induction of LDL receptor-related protein during the differentiation of monocyte-macrophages: possible involvement in the atherosclerotic process. Arterioscler. Thromb. 14:1000-1006.
23. Ballew, H.C. 1992. Neutralization. In Clinical Virology Manual. S. Specter, and G. Lancz, editors. Elsevier Science Publishing Co., New York. 229-241.
24. Matsumoto, A., M. Naito, H. Itakura, S. Ikemoto, H. Asaoka, I. Hayakawa, H. Kanamori, H. Ahuratani, F. Takaku, H. Suzuki, Y. Kobari, T. Miyai, K. Takahashi, E.H. Cohen, R. Wydro, D.E. Housman, and T. Kodama. 1990. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87:9133-9137.
25. Weinshenker, B.G., S. Wilton, and G.P.A. Rice. 1988. Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. H. Immunol. 140:1625-1631.
26. Sack, M.N., D.J. Rader, and R.O. Cannon. 1994. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet (N. Am. Ed.), 343:269-270.
27. Goldstein, J.L., S.K. Basu, and M.S. Brown. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98: 241-260.
28. Wu, H., K. Moulton, A. Horvai, S. Parik, and C.K. Glass. 1994. Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene. Mol. Cell. Biol. 14:2129-2139.
29. Ghazal, P., J. Young, E. Giulietti, C. Demattei, J. Garcia, R. Gaynor, R.M. Stenberg, and J.A. Nelson. 1991. A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins. J. Virol. 65:6735-6742.
30. Yurochko, A., T.F. Kowalik, S.M. Huong, and E.S. Huang. 1995. Human cytomegalovirus upregulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoters. J. Virol. 69:5391-5400.
31. Stein, J., H.D. Volk, C. Liebenthal, D.H. Kruger, and S. Prosch. 1993. Tumour necrosis factor α stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J. Gen. Viol. 74:2333-2338.
32. Pitas, R.E. 1990. Expression of the acetyl low density lipoprotein receptor by rabbit fibroblasts and smooth muscle cells. J. Biol. Chem. 265:12722-12727.
33. Huang, E.S., and T. Kowalik. 1993. The pathogenicity of human cytomegalovirus. In Molecular Aspects of Human Cytomegalovirus Diseases. Y. Beker, and G. Darai, editors. Springer-Verlag, Berlin. 1-45.
34. Bruggeman, C.A. 1993. Cytomegalovirus and latency: an overview. Virchows Archiv. B Cell Pathol. 64:385-333.
35. Meinick, J.L., and M.E. Debakey. 1993. Cytomegalovirus and atherosclerosis. Eur. Heart J. 14(Suppl. K):30-38.
36. Speir, E., R. Modali, E.S. Huang, M.B. Leon, F. Shawl, T. Finkel, and S.E. Epsiein. 1994. Potential role of human Cytomegalovirus and p53 interaction in coronary restenosis. Science (Wash. DC). 265:391-394.
37. Zhou, Y.F, M. Shou, R. Guzman, E. Guetta, T. Finkel, and S.E. Epstein. 1995. Cytomegalovirus infection increases neointimal formation in the rat model of balloon injury. J. Am. Coll. Cardiol. (Suppl.):242a. (Abstr.)
38. Zhou, Y.F., M.B. Leon, M.A. Wadawiw, J.J. Popma, Z.X. Yu, T. Finkel, and S.E. Epstein. 1996. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N. Engl. J. Med. 335:624-630.
39. Ho, M. 1991. Abortive, persistent, and latent infections in cell cultures. In Cytomegalovirus: Biology and Infection. Plenum Publishing Co., New York. 87-94.
40. Kodama, T., M. Freeman, L. Rohrer, J. Zabrecky, P. Matsudaira, and M. Krieger. 1990. Type I macrophage scaventer receptor contains α-helical and collagen-like coiled coils. Nature (Lond.). 343:531-535.
41. Rohrer, L., M. Freeman, T. Kodama, M. Penman, M. Krieger. 1990. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature (Lond.). 343:570-572.
42. Envi, M., H. Asaoka, A. Matsumoto, H. Itakura, Y. Kurihara, Y. Wada, H. Kanamori, Y. Yazaki, E. Takahashi, M. Lepert et al. 1993. Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J. Biol. Chem. 268:2120-2125.
43. Horvai, A., W. Palinski, H. Wu, K.S. Moulton, K. Kalla, and C.K. Glass. 1995. Scavenger receptor A gene regulatory elements target gene expression to macrophages and to loam cells of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 92:5391-5395.
44. Ottnad, E., S. Parthasarathy, G.R. Sambrano, M.P. Ramprasad, O. Quehenberger, N. Kondratenko, S. Green, and D. Steinberg. 1995. A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged celis. Proc. Natl. Acad. Sci. USA. 92:1391-1395.
45. Sambrano, G.R., and D. Steinberg. 1995. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc. Natl. Acad. Sci. USA. 92:1396-1400.
46. Endemann, G., L.W. Stanton, K.S. Madden, C.M. Bryant, R.T. White, and A.A. Protter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268:11811-11816.
47. Stanton, L.W., R.T. White, C.M. Bryant, A.A. Protter, G. Endemann. 1992. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J. Biol. Chem. 267:22446-22451.
48. Ramprasad, M.P., W. Fischer, J.L. Witztum, G.R. Sambrano, O. Quehenberger, and D. Steinberg. 1995. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc. Natl. Acad. Sci. USA. 92:9580-9584.
49. Acton, S., A. Rigotti, K.T. Landschulz, S. Xu, H.H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science (Wash. DC). 271:518-520.
50. Sparrow, C.P., S. Parthasarathy, and D. Steinberg. 1989. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J. Biol. Chem. 264:2599-2604.
51. Bickel, P.E., and M.W. Freeman. 1992. Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells. J. Clin. Invest. 90:1450-1457.
52. Dejager, S., M. Mietus-Snyder, and R.E. Pitas. 1993. Oxidized low density lipoproteins bind to the scavenger receptor expressed by rabbit smooth muscle cells and macrophages. Arterioscler. Thromb. 13:371-378.
53. Li, H., M.W. Freeman, and P. Libby. 1995. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J. Clin. Invest. 95:122-133.
54. Gong, Q., and R.E. Pitas. 1995. Synergistic effects of growth factors on the regulation of smooth muscle cell scavenger receptor activity. J. Biol. Chem. 270:21672-21678.
55. Speir, E., T. Shibutani, Z.X. Yu, and S.E. Epstein. 1995. The antioxidant N-Acetylcysteine inhibits, in vascular smooth muscle cells, cytomegalovirus replication, cytopathic effects, and activation of the cytomegalovirus promoter by 1E72. Circulation. 92:1-231. (Abstr.)
56. Guetta, E., V. Guetta, and S.E. Epstein. 1995. Cytomegalovirus interaction with monocytes, endothelial cells, and oxidized low density lipoprotein - a possible model for viral reactivation and atherosclerosis development. Circulation. 92:1-161. (Abstr.)